Opis działalności
Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. With the right combination of size and agility, the company continue to push themselves as a business and as individuals to deliver positive change.
Zarząd & Rada nadzorcza
| CEO |
| David Loew |
| Zarząd |
| Yan Moore M.D., Aymeric Le Chatelier, Aidan Murphy Ph.D., Craig Marks, Francois Garnier, Gwenan White, Regis Mulot, Dominique Bery, Alexander McEwan |
| Rada nadzorcza |
| - |
Dane firmy
| Nazwa: |
Ipsen SA |
| Adres: |
65, quai Georges Gorse,65, quai Georges Gorse Boulogne-Billancourt 92100 |
| Telefon: |
+33 1 58 33 50 00 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.ipsen.com |
| Przemysł: |
Biotechnologia |
| Sektor: |
Biotechnologia |
| Podsektor: |
Biotechnologia |
| Koniec roku finansowego: |
31.12 |
| Free float: |
41,52% |
| Data IPO: |
01.12.2005 |
Relacje inwestorskie
| Nazwa: |
Craig Marks |
| Telefon: |
+44 7584 349 193 |
| Fax: |
- |
| E-mail: |
-
|
